Breast cancer in China.

By L. Fan, K. Strasser-Weippl, Junjie Li, J. St. Louis, D. Finkelstein, Keda Yu, Wanqing Chen, Z. Shao, P. Goss. The Lancet Oncology, 2014

1,366 citations recorded by the source corpus.

Subfields: Genetics, Oncology

View Paper: https://www.semanticscholar.org/paper/e56c2efa976d6c8c67c61d1aa8ab5bd5fa37de8c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Ruihua Xu
2. H. Qiu
3. S. Cao

Citations in the corpus

• Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 (2021, background): “Over the past 35 years, the incidence and mortality rates of liver cancer [6], stomach cancer [7], esophageal cancer [8], and cervical cancer [9] have stayed high, while that of lung cancer [10], breast cancer [11], colorectal cancer [12], and prostate cancer [13] has been growing very fast in China”